期刊文献+

肠易激综合征不同中医证型与5-HT的相关性研究 被引量:8

Research of the Relevance between 5-Hydroxy Tryptamine and Differentiated Types of Traditional Chinese Medicine in Irritable Bowel Syndrome
下载PDF
导出
摘要 目的从胃肠神经-内分泌学的角度探讨肠易激综合征中医证型的病理实质。方法选肝郁气滞证、肝气乘脾证和脾胃虚弱证三种中医证型的患者及正常对照者各20例,采用荧光分光光度法测定血清中5-HT的浓度,比较血清5-HT浓度在三个证型中的变化。结果肝气乘脾证和脾胃虚弱证中血清5-HT的浓度升高显著,且肝气乘脾证有高于脾胃虚弱证的趋势。结论5-HT有可能成为IBS中医微观辨证的客观依据之一。 Objective To explore the pathogenic substance of the differentiated TCM types of irritable bowel syndrome (IBS) in view of gastrointestinal nerve - endocrinology. Methods Three TCM differentiated types, named liver qi stagnation,liver qi overacting the spleen and deficiency of the spleen and stomach ; as well as normal control groups were divided ,20 cases in each one. The spectrofluorophotometry was adopted to detect the concentration of 5 - HT in serum and compare the changes of 5 - HT concentration in serum among three differentiated syndromes of TCM. Results The concentration of 5 - HT in serum increased sig- nificantly in either liver qi stagnation or deficiency of the spleen and stomach. The concentration of 5 - HT was higher in tendency than that in deficiency of the spleen and stomach syndrome. Conclusion 5 - HT is probably one of the objective evidences for the microcosmic syndrome differentiation of IBS in traditional Chinese medicine.
机构地区 北京中医药大学
出处 《世界中西医结合杂志》 2009年第11期805-806,共2页 World Journal of Integrated Traditional and Western Medicine
基金 北京中医药大学2009年度科研基金资助项目(No.2008-×-068)
关键词 肠易激综合征 中医证型 5-羟色胺 Irritable bowel syndrome Differentiated types of TCM 5 -HT
  • 相关文献

参考文献2

二级参考文献19

  • 1袁耀宗,许斌,莫剑忠,王吉耀,李兆申.马来酸曲美布汀治疗肠易激综合征的疗效和安全性研究[J].胃肠病学,2005,10(3):143-147. 被引量:107
  • 2杨欣艳,李世荣.微生态制剂在肠易激综合征治疗中的作用[J].中华医学杂志,2005,85(39):2802-2804. 被引量:16
  • 3Saito YA, Schoenfeld, Locke GRI 3rd. The epidemiology of irritable bowel syndrome in North America: a systemic review. Am J Gastroenterol, 2002, 97 : 1910-1915.
  • 4Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmarcol Ther, 2004, 19 : 1217-1224.
  • 5Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology, 2002, 123: 2108-2131.
  • 6Devaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut, 2002, 51(Suppl 1): i67-i71.
  • 7Drossman DA, Ringel Y, Vogt BA, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gasroenterology, 2003, 124:754-761.
  • 8Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut, 2004, 53:1096-1101.
  • 9Longstreth GF, Thompson WG, Chey WD. Functional bowel disorders// Drossman DA. Rome Ⅲ : the functional gastrointertinal disorders. 2006:487-555.
  • 10Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther, 1997, 11:553-559.

共引文献438

同被引文献100

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部